Last Updated: November 8, 2026

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Patent Profile

Name: NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Neomycin And Polymyxin B Sulfates And Bacitracin Zinc patents expire, and what generic alternatives are available?

Neomycin And Polymyxin B Sulfates And Bacitracin Zinc is a drug marketed by Bausch And Lomb Inc, Padagis Us, and Sciegen Pharms. and is included in three NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?

Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

US Patents:	0
Applicants:	3
NDAs:	3
Finished Product Suppliers / Packagers:	1
What excipients (inactive ingredients) are in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC excipients list
DailyMed Link:	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC at DailyMed

Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

Drug Class	Aminoglycoside Antibacterial Polymyxin-class Antibacterial
Physiological Effect	Decreased Cell Wall Synthesis & Repair

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb Inc	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	064064-001	Oct 30, 1995	AT	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Padagis Us	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	060764-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	065088-001	Feb 6, 2004		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.